ECOMED: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ECOMED
Largest movements
- Financial fixed assets +€200,000
new in 2024: €200,000
- Receivables within one year -€198,630
no longer reported in 2024 (was €198,630)
- Cash -€9,204
down €9,204 (-88.6%), from €10,394 to €1,190
mainly Investment in fixed assets (net) (-€200,000) and Net result for the year (-€34,218)
- Profit (loss) carried forward -€34,218
down €34,218 (-23.2%), from €147,591 to €113,373
- Other debts +€30,713
new in 2024: €30,713
- Trade debts -€3,058
down €3,058 (-95.5%), from €3,202 to €143
- Gross operating margin -€231,394
down €231,394, from €197,698 to -€33,696
- Taxes -€49,197
no longer reported in 2024 (was €49,197)
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €209,990 | €203,814 | -€6,176 | -2.9% |
| Fixed assets | 21/28 | - | €200,000 | +€200,000 | |
| Financial fixed assets | 28 | - | €200,000 | +€200,000 | |
| Current assets | 29/58 | €209,990 | €3,814 | -€206,176 | -98.2% |
| Amounts receivable within one year | 40/41 | €198,630 | - | -€198,630 | |
| Other amounts receivable | 41 | €198,630 | - | -€198,630 | |
| Cash at bank and in hand | 54/58 | €10,394 | €1,190 | -€9,204 | -88.6% |
| Deferred charges and accrued income | 490/1 | €966 | €2,624 | +€1,658 | +171.5% |
| Total equity and liabilities | 10/49 | €209,990 | €203,814 | -€6,176 | -2.9% |
| Equity | 10/15 | €157,591 | €123,373 | -€34,218 | -21.7% |
| Contributions | 10/11 | €10,000 | €10,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €147,591 | €113,373 | -€34,218 | -23.2% |
| Amounts payable | 17/49 | €52,399 | €80,441 | +€28,042 | +53.5% |
| Amounts payable within one year | 42/48 | €52,399 | €80,054 | +€27,655 | +52.8% |
| Trade debts | 44 | €3,202 | €143 | -€3,058 | -95.5% |
| Suppliers | 440/4 | €3,202 | €143 | -€3,058 | -95.5% |
| Taxes, remuneration and social security | 45 | €49,197 | €49,197 | = | 0.0% |
| Taxes | 450/3 | €49,197 | €49,197 | = | 0.0% |
| Other amounts payable | 47/48 | - | €30,713 | +€30,713 | |
| Accrued charges and deferred income | 492/3 | - | €387 | +€387 | |
| Other operating charges | 640/8 | €732 | €387 | -€345 | -47.1% |
| Gross operating margin | 9900 | €197,698 | -€33,696 | -€231,394 | |
| Operating profit (loss) | 9901 | €196,966 | -€34,083 | -€231,049 | |
| Financial charges | 65/66B | €178 | €135 | -€43 | -23.9% |
| Recurring financial charges | 65 | €178 | €135 | -€43 | -23.9% |
| Profit (loss) for the period before taxes | 9903 | €196,789 | -€34,218 | -€231,007 | |
| Income taxes | 67/77 | €49,197 | - | -€49,197 | |
| Profit (loss) for the period | 9904 | €147,591 | -€34,218 | -€181,809 | |
| Profit (loss) for the period to be appropriated | 9905 | €147,591 | -€34,218 | -€181,809 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.